By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Google Announces New Privacy Updates to Limit User Tracking
Google announced it will be updating its privacy restrictions that will limit tracking throughout apps on android devices. The update is similar to Apple's previous update, which ended up causing companies like Meta to lose billions of dollars on the market. Cheddar News was joined by David Trainer, CEO of New Constructs, to discuss the implications of the new privacy updates.
Global Semiconductor Sales Reach Record Highs in 2021; What's Next?
Global semiconductor sales topped $500 billion dollars for the first time in history in 2021. Demand for microchips has been at an all-time high amid a global shortage, but questions still remain about the future of semiconductor production. Cheddar News was joined by Tristan Gerra, Senior Research Analyst at Baird, to answer some of these questions and more.
Real Estate Platform Compass CEO on Q4 Revenue Jump, Agent Retention
Compass Inc. reported its Q4 earnings on Wednesday, noting a 31 percent surge in quarterly revenue year over year. The real estate brokerage platform allows agents to promote and market their properties online and saw a 90 percent agent retention rate as well. Compass CEO Robert Reffkin joined Cheddar News to discuss the company's earnings, what ongoing inflation means for the housing market and how they help agents directly. "Let me start by saying my mom is actually a real estate agent, has been the majority of my life. She's a real estate agent today at Compass, and so I built Compass with her in mind," Reffkin said. The goal for an agent is to grow their business and have a better quality of life, more income to support their family, more time to be with their family, and it's not just software. It's a platform of software and services."
Ads During NFL's Big Game Look Toward The Future
While many are excited to watch the final two NFL teams square-off and see which one ultimately takes home the trophy, some, on the other hand, are there for another mian attraction -- the commercials. Companies during this year's game are looking towards the future From electric vehicles, to robots, and crypto-currency, several first-time advertisers are expected to join long-time advertisers like Pepsi, Budweiser and Doritos during the NFL's biggest game. Tom Morton, Global Chief Strategy Officer at R/GA, joined Cheddar News' Big Game Special to discuss.
Godiva GMO On 2022 Chocolate Trends
Americans are expected to spend nearly $24 billion in 2022 for Valentine's Day, and many of those gifts will be in the form of chocolate. John Galloway, interim president of the Americas and CMO of Godiva, joined Cheddar's Opening Bell to discuss what chocolate trends the brand is seeing this year, plus the impact of inflation and supply chain issues on the industry.
Load More